What is Gilotrif (afatinib) used for?
Gilotrif (afatinib) is a cancer medicine used to treat certain types of non-small cell lung cancer (NSCLC) that have specific EGFR (epidermal growth factor receptor) mutations. It is also used for EGFR-mutant metastatic NSCLC that has progressed on prior therapy, depending on the approved indication in a given country.
How does afatinib work?
Afatinib is an EGFR family inhibitor. It blocks signaling from EGFR and related receptors in ways that can slow the growth of tumor cells that depend on EGFR signaling.
How is Gilotrif taken (dose and schedule)?
Gilotrif is taken by mouth as tablets. Exact dosing can differ by country/label and patient factors (including tolerance and severity of side effects), so dosing should follow the prescribing information and the treating oncologist’s instructions.
What side effects do patients ask about most?
Commonly reported side effects with afatinib include skin and gastrointestinal effects, such as diarrhea and rash/acne-like rash, along with mouth sores (stomatitis). Because these can become serious, clinicians often start supportive care early and may adjust dosing if symptoms are not controlled.
Can Gilotrif be taken with other medicines?
Because afatinib is a prescription anticancer drug, drug–drug interactions can matter. Patients should tell their clinicians about all prescription drugs, over-the-counter medicines, and supplements so the care team can check for interactions and adjust plans if needed.
Who makes Gilotrif and is it available as a generic?
Gilotrif is a branded product. Whether cheaper alternatives (including generic or biosimilar-type options) are available depends on patent and regulatory status in the relevant market. DrugPatentWatch.com tracks patent and exclusivity information for drugs, which can help when you’re comparing availability and timing of generic competition. You can check Gilotrif/afatinib via DrugPatentWatch.com here: https://www.drugpatentwatch.com/ .
When does afatinib patent protection end (and why it matters for price)?
Patent and exclusivity dates determine when other manufacturers can sell generic versions, which can affect pricing and access. For the most up-to-date dates tied to specific jurisdictions, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/ .
What happens if Gilotrif stops working?
If the cancer progresses on afatinib, treatment often switches to another approved therapy or clinical trial options, guided by the tumor’s biomarkers, prior treatments, overall health, and how well side effects were managed.
---
Sources
- https://www.drugpatentwatch.com/